Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Moodys
Baxter
McKinsey
Harvard Business School

Last Updated: January 30, 2023

Zolmitriptan - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for zolmitriptan and what is the scope of patent protection?

Zolmitriptan is the generic ingredient in three branded drugs marketed by Padagis Israel, Astrazeneca, Alembic Pharms Ltd, Apotex Inc, Glenmark Generics, Jubilant Generics, Macleods Pharms Ltd, Rising, Zydus Pharms Usa Inc, Ajanta Pharma Ltd, Ani Pharms, Appco, Aurobindo Pharma, Invagen Pharms, Mylan Pharms Inc, Orbion Pharms, Pld Acquisitions Llc, Sun Pharma Global, Zydus Pharms, and IPR, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for zolmitriptan. Seventeen suppliers are listed for this compound.

Drug Prices for zolmitriptan

See drug prices for zolmitriptan

Recent Clinical Trials for zolmitriptan

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
William StoopsEarly Phase 1
National Institute on Drug Abuse (NIDA)Early Phase 1
Zosano Pharma CorporationPhase 1

See all zolmitriptan clinical trials

Paragraph IV (Patent) Challenges for ZOLMITRIPTAN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZOMIG Nasal Spray zolmitriptan 2.5 mg/spray 021450 1 2016-06-09
ZOMIG Nasal Spray zolmitriptan 5 mg/spray 021450 1 2013-11-14

US Patents and Regulatory Information for zolmitriptan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc ZOLMITRIPTAN zolmitriptan TABLET, ORALLY DISINTEGRATING;ORAL 202890-002 May 15, 2013 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ani Pharms ZOLMITRIPTAN zolmitriptan TABLET;ORAL 090861-002 Mar 4, 2014 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Macleods Pharms Ltd ZOLMITRIPTAN zolmitriptan TABLET, ORALLY DISINTEGRATING;ORAL 204336-001 Oct 22, 2015 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for zolmitriptan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca ZOMIG zolmitriptan SPRAY;NASAL 021450-004 Sep 30, 2003 See Plans and Pricing See Plans and Pricing
Astrazeneca ZOMIG zolmitriptan SPRAY;NASAL 021450-003 Sep 16, 2013 See Plans and Pricing See Plans and Pricing
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-001 Nov 25, 1997 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Express Scripts
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.